+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Spinal Stenosis - Market Insights, Competitive Landscape and Market Forecast - 2026

  • ID: 5345913
  • Drug Pipelines
  • June 2021
  • Region: Global
  • DelveInsight

FEATURED COMPANIES

  • Medtronic
  • NuVasive, Inc.
  • Paradigm Spine
  • Sintea Biotech S.p.A.
  • Spinal Simplicity LLC
  • Stryker Corp
  • MORE
This ‘Spinal Stenosis - Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of spinal stenosis and the historical and forecasted spinal stenosis market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

The Spinal Stenosis market report provides an overview of spinal stenosis devices, applications of these devices as well as its PEST Analysis. Additionally, the report provides insight on the spinal stenosis market share of the individual devices, current and forecasted spinal stenosis market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Spinal Stenosis Understanding


Spinal Stenosis Overview


Spinal Stenosis is a condition in which the gaps inside the spine narrow, putting pressure on the nerves that run through it. It is most common in the lower back and neck. With age, the ligaments of the spinal column, especially the ligamentum flavum, stiffen, become less flexible, and thicken, contributing to Spinal Stenosis. The degeneration of both the facet joints and the intervertebral discs causes this narrowing.

Geography Covered

  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan
Study Period: 2018-2026

List of Companies

  • Boston Scientific Corporation
  • Stryker
  • Medtronic
  • Sintea Biotech
  • Surgalign
  • Spinal Simplicity LLC
  • Zimmer Biomet
  • Nuvasive Inc.
  • Globus Medical Inc.
  • Orthofix International NV
  • Alphatec Spine Inc.
  • Premia Spine
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • NEO-MEDICAL SA
  • Vertebral Technologies, Inc.

Spinal Stenosis - Competitive Analysis


This segment of the report provides a brief competitive analysis of spinal stenosis to help understand the competition in the market. It gives a comparative understanding of the products based on parameters such as type of regulatory approval.

Spinal Stenosis: Market Segmentation


By Product Type

  • Interspinous Spacers
  • Stabilization Systems
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Spinal Stenosis: Diagnosed Prevalent Patient Population

This segment of the report provides an analysis of the eligible patient pool that incorporate spinal stenosis for their treatment, across 7MM during the study period (2018 and 2026).

Spinal Stenosis: Market Analysis


This segment illustrates the market of spinal stenosis across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR of XX%.

Spinal Stenosis: Market Dynamics


The report provides insights into the market driving factors and the barriers shaping the spinal stenosis market.

Market Drivers

  • Rising cases of spinal stenosis among the growing geriatric population
  • The rising incidence of spinal injury
  • Technological advancements in product development
  • Favorable reimbursement policies
  • Increase in the number of product offerings

Market Barriers

  • High cost of treatment procedures
  • Risk associated with procedures
  • Stringent product approval process

KOL Views


To keep up with the market trends, the publisher takes KOLs and SME's opinion working in spinal stenosis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or spinal stenosis market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of spinal stenosis, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available spinal stenosis is provided, which will have an impact on the future market of spinal stenosis.
  • A detailed review of spinal stenosis market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the spinal stenosis market.

Report Highlights

  • The report covers descriptive overview of the spinal stenosis, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the spinal stenosis market.
  • The report also reviews the detailed historical and forecasted spinal stenosis market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the spinal stenosis market.

Spinal Stenosis Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size
  • Eligible Patient Pool

Spinal Stenosis Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL'S views
  • PEST Analysis

Key Questions Answered


Market Insights:

  • What was the spinal stenosis market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the spinal stenosis total market size as well as market size by devices across the 7MM during the forecast period (2018-2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest spinal stenosis market size during the forecast period (2018-2026)?
  • At what CAGR, the spinal stenosis market is expected to grow in the 7MM during the forecast period (2018-2026)?
  • What will be the spinal stenosis market outlook across the 7MM during the forecast period (2018-2026)?
  • What will be the spinal stenosis market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Competitive Landscape:

  • What are the current devices available in the spinal stenosis?
  • What is the spinal stenosis available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing spinal stenosis?
  • What are the key collaborations (Industry-Industry), Mergers and acquisitions, licensing activities related to the spinal stenosis?
  • What are the key designations that have been granted for the current spinal stenosis?
  • What are the 7MM countries historical and forecasted market of spinal stenosis?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Medtronic
  • NuVasive, Inc.
  • Paradigm Spine
  • Sintea Biotech S.p.A.
  • Spinal Simplicity LLC
  • Stryker Corp
  • MORE
1 Key Insights

2 Report Introduction

3 Executive Summary Of Spinal Stenosis Devices

4 Spinal Stenosis Devices: Background And Overview
4.1 Introduction
4.2 Types of Spinal Stenosis
4.2.1 Cervical Spinal Stenosis
4.2.2 Lumbar Spinal Stenosis
4.3. Pathophysiology
4.4 Prognosis of the Disease
4.5 Symptoms
4.5.1 Lumbar Stenosis Symptoms
4.5.2 Cervical Stenosis Symptoms
4.6. Diagnosis
4.6.1 Preoperative Diagnosis
4.6.2 Postoperative Diagnosis
4.7 Treatment
4.7.1 Pharmacological Treatment
4.7.2 Non-pharmacological Treatment
4.8 Medical Devices used in the Treatment of Spinal Stenosis
4.8.1 Interspinous Spacer Devices
4.8.2 Plates or Rods with Pedicle Screws
4.8.3 Stabilization Systems
4.8.4 Risk Factors Associated With Devices
4.9 Risk Factors Associated With The Disease
4.10 Future Developments for the Treatment of Spinal Stenosis

5. Spinal Stenosis: Regulatory Approval and Reimbursement Scenario
5.1 Spinal Stenosis: Regulatory Approval
5.1.1 United States Regulation of Spinal Stenosis
5.1.2 European Regulation of Spinal Stenosis
5.1.3 Japan Regulation of Spinal Stenosis
5.2. Spinal Stenosis: Reimbursement Scenario
5.2.1 Reimbursement Scenario in the United States
5.2.2 Reimbursement Scenario in Europe
5.2.3 Reimbursement Scenario in Japan

6 Spinal Stenosis: Competitive Assessment
6.1 Key Cross Competition of Marketed Spinal Stenosis based on Product Type
6.2 Key Cross Competition of Marketed Spinal Stenosis based on Type
6.3 Key Cross Competition of Marketed Spinal Stenosis based on Approval
6.4 Company and Product Profiles
6.4.1 Spinal Simplicity LLC
6.4.2 Boston Scientific Corporation
6.4.3 Medtronic plc
6.4.4 Stryker Corporation
6.4.5 Surgalign
6.4.6 Zimmer Biomet
6.4.7 Nuvasive Inc
6.4.8 Sintea Biotech
6.4.9 Orthofix Medical Inc
6.4.10 Globus Medical Inc
6.4.11 Alpha Tech Spine Inc.
6.4.12 Johnson & Johnson
6.4.13 NEO-MEDICAL SA
6.4.14 Vertebral Technologies Inc
6.4.15 Premia Spine
6.4.16 B. Braun Melsungen AG

7 Assumptions and Rationale
7.1 7MM: Diagnosed Prevalent Patient Population
7.1.1 Diagnosed Prevalent Patient Population for Spinal stenosis
7.1.2 Type-Specific Prevalent Cases of Spinal Stenosis in the 7MM
7.1.3 Treatable Patient Pool by Treatment Type in the 7MM

8 Country-wise Patient Population of Spinal Stenosis
8.1 The United States
8.1.1 Diagnosed Prevalent Patient Population for Spinal stenosis in the United States
8.1.2 Type-Specific Prevalent Cases of Spinal Stenosis in the United States
8.1.3 Treatable Patient Pool by Treatment Type in the United States
8.2 Germany
8.2.1 Diagnosed Prevalent Patient Population for Spinal stenosis in Germany
8.2.2 Type-Specific Prevalent Cases of Spinal Stenosis in Germany
8.2.3 Treatable Patient Pool by Treatment Type in Germany
8.3 France
8.3.1 Diagnosed Prevalent Patient Population for Spinal stenosis in France
8.3.2 Type-Specific Prevalent Cases of Spinal Stenosis in France
8.3.3 Treatable Patient Pool by Treatment Type in France
8.4 Spain
8.4.1 Diagnosed Prevalent Patient Population for Spinal stenosis in Spain
8.4.2 Type-Specific Prevalent Cases of Spinal Stenosis in Spain
8.4.3 Treatable Patient Pool by Treatment Type in Spain
8.5 Italy
8.5.1 Diagnosed Prevalent Patient Population for Spinal stenosis in Italy
8.5.2 Type-Specific Prevalent Cases of Spinal Stenosis in Italy
8.5.3 Treatable Patient Pool by Treatment Type in Italy
8.6 The United Kingdom
8.6.1 Diagnosed Prevalent Patient Population for Spinal stenosis in the UK
8.6.2 Type-Specific Prevalent Cases of Spinal Stenosis in the UK
8.6.3 Treatable Patient Pool by Treatment Type in the UK
8.7 Japan
8.7.1 Diagnosed Prevalent Patient Population for Spinal stenosis in Japan
8.7.2 Type-Specific Prevalent Cases of Spinal Stenosis in Japan
8.7.3 Treatable Patient Pool by Treatment Type in Japan

9 Spinal Stenosis: Market Analysis
9.1 Spinal Stenosis Market Size in the 7MM
9.2 Spinal Stenosis Market Share by Product Type in the 7MM
9.3 Spinal Stenosis Market Share by End User in the 7MM

10. Country-wise Market Size of Spinal Stenosis
10.1 United States
10.1.1 Spinal Stenosis Market Size in the United States
10.1.2 Spinal Stenosis Market Share by Product Type in the United States
10.1.3 Spinal Stenosis Market Share by End User in the United States
10.2 Germany
10.2.1 Spinal Stenosis Market Size in Germany
10.2.2 Spinal Stenosis Market Share by Product Type in Germany
10.2.3 Spinal Stenosis Market Share by End User in Germany
10.3 France
10.3.1 Spinal Stenosis Market Size in France
10.3.2 Spinal Stenosis Market Share by Product Type in France
10.3.3 Spinal Stenosis Market Share by End User in France
10.4 Spain
10.4.1 Spinal Stenosis Market Size in Spain
10.4.2 Spinal Stenosis Market Share by Product Type in Spain
10.4.3 Spinal Stenosis Market Share by End User in Spain
10.5 Italy
10.5.1 Spinal Stenosis Market Size in Italy
10.5.2 Spinal Stenosis Market Share by Product Type in Italy
10.5.3 Spinal Stenosis Market Share by End User in Italy
10.6 The United Kingdom
10.6.1 Spinal Stenosis Market Size in the UK
10.6.2 Spinal Stenosis Market Share by Product Type in the UK
10.6.3 Spinal Stenosis Market Share by End User in the UK
10.7 Japan
10.7.1 Spinal Stenosis Market Size in Japan
10.7.2 Spinal Stenosis Market Share by Product Type in Japan
10.7.3 Spinal Stenosis Market Share by End User in Japan

11. Patient Testimonial

12. Patient Case Study

13. Supporting Associations

14. KOL Views

15. Market Drivers

16. Market Barriers

17. Unmet Needs

18. PEST Analysis

19. Appendix
19.1 Bibliography
19.2 Report Methodology

20. Publisher Capabilities

21. Disclaimers

22. About the Publisher
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Medtronic
  • Stryker Corp
  • Sintea Biotech S.p.A.
  • Paradigm Spine
  • Spinal Simplicity LLC
  • Boston Scientific Corporation
  • Zimmer Biomet
  • NuVasive, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll